To further assess the effect of the simultaneous treatment with CaMKII and NK1R inhibitors on GBM tumorigenesis by GSCs in vivo, we used a chick chorioallantoic membrane (CAM) tumor model implanted with U87MG GSCs. This evidence concerns the gene CAMK2G and neoplasm.